Bookmark

Add to MyYahoo RSS

Neogen News

News on Neogen (Ticker: NEOG) continually updated from thousands of sources around the net.

Wednesday | AmericanBankingNews.com

Neogen Upgraded by TheStreet to "Buy"

The analysts wrote, "Neogen Corporation has been upgraded by TheStreet Ratings from hold to buy.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Apr 02, 2014

AmericanBankingNews.com

Insider Selling: Neogen VP Unloads 41,022 Shares of Stock

Neogen VP Edward Bradley sold 41,022 shares of the stock on the open market in a transaction dated Tuesday, April 1st.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Mar 31, 2014

SBWire

Pet Pancreas Aid - PanaKare Plus Powder

PanaKare plus Powder, manufactured by the Neogen Corporation, is a concentrated form of pancreatic enzymes containing vitamins A, D, and E. PanaKare plus Powder is prescribed to patients with acute and chronic Pancreatitis.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Fri Mar 28, 2014

AmericanBankingNews.com

Insider Selling: Terri A. Morrical Unloads 13,950 Shares of Neogen Stock

Neogen VP Terri A. Morrical sold 13,950 shares of the stock in a transaction that occurred on Wednesday, March 26th.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Mar 26, 2014

Seeking Alpha

Neogen Priced Like The Excellent Company It Is

Food safety remains a work in progress in the absence of FDA guidelines, but growing opportunities in China, India, and Brazil merit watching.

Comment?

Related Topix: Biotech, Healthcare Industry, Food Science, Food and Drug Administration

AmericanBankingNews.com

Neogen Corp. PT Raised to $53.00

Roth Capital's target price would suggest a potential upside of 12.57% from the company's current price.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Mar 25, 2014

Freshnews

Neogen reports third quarter results

Neogen Corporation announced today that its revenues for the third quarter of FY 2014, which ended Feb. 28, increased 21% to $61,996,000, from the previous year's third quarter revenues of $51,055,000.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marketing

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••